Cut-off Values of Muscle Thickness Ratio for Sarcopenia

August 10, 2019 updated by: Ozden Ozkal, Hacettepe University

Cut-off Values and Adjustments for Diagnosing Sarcopenia

The loss of muscle mass is one of the major diagnostic criteria for sarcopenia. Many methods are also used for the definition of sarcopenia. However there is no information about cut-off values in this respect in the literature. Therefore, the aim of this study is to determine the cut-off values of this ratio for confirming the diagnosis of sarcopenia.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Decreases in total skeletal muscle mass are accepted to be necessary for confirming the diagnosis of sarcopenia. Many methods are also used for the definition of sarcopenia.

However, ultrasound measurements has a high sensitivity and specify for confirming the diagnosis of sarcopenia. However there is no information about cut-off values in this respect in the literature. Therefore, the aim of this study is to determine the cut-off values of this ratio for confirming the diagnosis of sarcopenia.

Study Type

Interventional

Enrollment (Actual)

292

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06100
        • Ozden Ozkal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • To be a volunteer to participate
  • To be an aged 18-90 years old.

Exclusion Criteria:

  • Walking with assist device
  • Having a visual deficits
  • Having an undergone orthopedic surgery
  • Having a cardiac pacemaker
  • Having a hypothyroidism, diabetes mellitus, renal/hepatic failure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group:young
Sixty older subjects will be evaluated in this study.
Ultrasonographic measurement is assessment method to diagnosis of sarcopenia
Active Comparator: Control Group:Middle-aged
Sixty middle-aged subjects will be evaluated in this study.
Ultrasonographic measurement is assessment method to diagnosis of sarcopenia
Experimental: Experimental group:older
Sixty older subjects will be evaluated in this study.
Ultrasonographic measurement is assessment method to diagnosis of sarcopenia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle thickness
Time Frame: 30 minutes
Muscle thickness in millimeters by Ultrasound.
30 minutes
Skeletal muscle mass
Time Frame: 2 minutes
Skeletal muscle mass will be evaluated by bioelectrical impedance analysis.The unit of measure is kg.
2 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle strength
Time Frame: 15 minutes
Muscle strength will be evaluated using an isokinetic dynamometer (Biodex Medical Systems, New York, USA). Knee and ankle muscle strength( flexion, extension, dorsiflexion and plantarflexion) will be evaluated. The unit of measure is Nm/kg.
15 minutes
Peripheral strength
Time Frame: 1 minutes
The peripheral (handgrip) strength will be measured with a dynamometer (JAMAR).Three measurements will be taken, whose average of the three measurements will be collected. The unit of measure is kg.
1 minutes
Physical function
Time Frame: 5 minutes
Physical function will be evaluated by short physical performance scale. The score of this scale range from 0 (worst performance) to 12 (best performance).
5 minutes
Anthropometric assessments
Time Frame: 5 minutes
Participants waist, hip and calf circumferences will be measured by tape measure. The unit of measure is centimeters.
5 minutes
Balance
Time Frame: 1 minute
Timed up and go test evaluates dynamic balance of participants. The timed up and go test measures the time that a patient needs to stand up from a chair, walk a 3-m distance, come back and sit back on the chair.Timed up and go test measure is second. The lower values indicates the better balance.
1 minute
Body mass index
Time Frame: 1 minute
Participants' weight and height will be evaluated by electronic weighing and tape measure, respectively. body mass index will be expressed in in kg/ m²
1 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

July 30, 2019

Study Completion (Actual)

August 9, 2019

Study Registration Dates

First Submitted

June 18, 2019

First Submitted That Met QC Criteria

June 19, 2019

First Posted (Actual)

June 20, 2019

Study Record Updates

Last Update Posted (Actual)

August 13, 2019

Last Update Submitted That Met QC Criteria

August 10, 2019

Last Verified

June 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Clinical Trials on Ultrasonographic evaluation

Subscribe